LEXARIA BIOSCIENCE CORP. Repayments of Long-Term Debt
LEXARIA BIOSCIENCE CORP. (LEXX) reported Repayments of Long-Term Debt of $0 for the 12-month period ending 2022-08-31, per its 10-K filed 2022-11-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2022-11-28
- LEXARIA BIOSCIENCE CORP. repayments of long-term debt for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- LEXARIA BIOSCIENCE CORP. repayments of long-term debt for fiscal 2021 was $22.74K.
| Period end | Repayments of Long-term Debt 12 month |
|---|---|
| 2022-08-31 | $0.00 10-K · filed 2022-11-28 |
| 2021-08-31 | $22.74K 10-K · filed 2022-11-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |